Publications by authors named "Chuwei Yu"

Claim this Profile
S
Synthesis and Anticancer Activity Evaluation of Novel Carborane-Containing Isoflavonoid Analogues.
Yirong Zhang, Chuwei Yu, Linyuan Wang, Lina Zhou, Chaofan Li, Changxian Yuan, Yuzhe Lin

ACS Omega· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.
Ziwei Luo, Chencen Lin, Chuwei Yu, Changxian Yuan, Wenyong Wu

Cancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-337-3p improves metabolic-associated fatty liver disease through regulation of glycolipid metabolism.
Xiaoding Xu, Chuwei Yu, Hongxiu He, Xiangyu Pan, Aijun Hou

iScience· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-552-3p Regulates Multiple Fibrotic and Inflammatory genes Concurrently in Hepatic Stellate Cells Improving NASH-associated Phenotypes.
Ningning Ma, Aijun Hou, Xiangyu Pan, Fuguang Sun, Xiaoding Xu, Chuwei Yu

Int J Biol Sci· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSAD Ameliorates Lipid Accumulation in High-Fat Diet-Fed Mice.
Rongrong Tan, Jiayang Li, Lu Liu, Qian Wu, Lei Fan, Chuwei Yu

Int J Mol Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment.
Chuwei Yu, Jing Chen, Jin Ren

Mol Biol Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-379-5p regulates free cholesterol accumulation and relieves diet induced-liver damage in db/db mice via STAT1/HMGCS1 axis.
Yunxia Dong, Chuwei Yu, Ningning Ma, Xiaoding Xu, Qian Wu

Mol Biomed· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice.
Xiaoding Xu, Yunxia Dong, Ningning Ma, Weiwen Kong, Chuwei Yu

Metabolism· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New PCSK9 inhibitor miR-552-3p reduces LDL-C via enhancing LDLR in high fat diet-fed mice.
Ningning Ma, Lei Fan, Yunxia Dong, Xiaoding Xu, Chuwei Yu

Pharmacol Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Self-directed learning in nursing students with different background factors].
Yu-Hsiu Kao, Chu-Wei Yu, Shu-Yi Kuo, I-Hsiu Kuang

Hu Li Za Zhi· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis